[Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
[Notices]
[Page 28058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting of 
the Sickle Cell Disease Advisory Committee

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Sickle Cell Disease Advisory Committee, National Heart, Lung, 
and Blood Institute, June 9, 1997. The meeting will be held at the 
National Institutes of Health, Rockledge II, Conference Room 9104, 6701 
Rockledge Drive, Bethesda, Maryland 20892.
    The entire meeting will be open to the public from 9:00 a.m. to 
adjournment, to discuss recommendations on the implementation and 
evaluation of the Sickle Cell Disease Program. Attendance by the public 
will be limited to space available.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact the Executive Secretary in advance of the meeting.
    Dr. Clarice D. Reid, Executive Secretary, Sickle Cell Disease 
Advisory Committee, Division of Blood Diseases and Resources, NHLBI, 
Two Rockledge Center, Suite 10160, 6701 Rockledge Drive, Bethesda, 
Maryland 20892, (301) 435-0080, will furnish substantive program 
information, a summary of the meeting, and a roster of the committee 
members.

(Catalog of Federal Domestic Assistance Program No. 93.839, Blood 
Diseases and Resources Research, National Institutes of Health)

    Dated: May 19, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-13526 Filed 5-21-97; 8:45 am]
BILLING CODE 4140-01-M